Skip to main content
ICUI logo

ICU Medical, Inc. (ICUI) Stock: Price, Forecast & Analyst Target

ICU Medical, Inc. (ICUI) — MoonshotScore 73/100 (Strong band), calculated Nov 18, 2026. Price $172.52 (-1.84%), as of the Nov 20, 2026 trading session; market cap $4.31B.

Educational signal · not a buy or sell recommendation · How to read this

$172.52 −$3.24 (-1.84%) Market Cap $4.31B

ICU Medical, Inc. · ICUI · NASDAQ

ICU Medical, Inc. specializes in developing, manufacturing, and selling medical devices for infusion therapy and critical care. Their products are utilized in hospitals, clinics, and alternate care facilities globally, focusing on patient safety and infection control.

Price as of Nov 20, 2026

Key Statistics

73 of 100

MoonshotScore v2 · ICU Medical (ICUI)

Strong
Business Quality Solid (73)
Financial Safety Strained (36)
Valuation Fair (63)
Growth Durability Compounding (82)
Momentum Surging (88)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and durable growth, but a strained balance sheet; the market is already moving on it. Business Quality: Solid; Financial Safety: Strained; Valuation: Fair; Growth Durability: Compounding; Momentum: Surging.

  • quarterly revenue $537M (Q3 FY2025, quarter ended Sep 2025)
  • EPS beat 0 of the last 4 reports
  • Altman Z 2.67 · Piotroski F 6

Helping: business quality, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for ICUI (58 recorded, newest six shown)
RecordedScoreBand
70Strong
70Strong
70Strong
73Strong
73Strong
73Strong

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$172.52
Change on the day-1.84%
Market capitalisation$4.31B—
Price / earnings (trailing)73.41
Shares traded on the day223.4K

Price & events

Other perspectives

Council score for ICU Medical (ICUI): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Weak
Valuation Moderate
Growth Durability Strong
Momentum Strong

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Weak
Debt/Equity Neutral
ROE Weak
Gross Margin Neutral

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

The Munger lens reads the current price as undervalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is ICU Medical (ICUI), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. ICU Medical, Inc. (ICUI) is listed on NASDAQ. It employs 13,000 people. In Q3 FY2025 it reported revenue of $537M and net income of -$3M. The market values it at $4.31B.

2 · Latest results

What do the latest results show for ICU Medical (ICUI)?

Short answer · as of

The most recent reported quarter, Q3 FY2025, carried revenue of $537M. Against analyst estimates the company has EPS beat 0 of the last 4 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2025$537M-$3M-$0.14 (diluted)
Q4 FY2025$541M-$16M-$0.64 (diluted)
Q1 FY2026$530M$30M$1.20 (diluted)
Q2 FY2026$552M$19M$0.76 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for ICU Medical (ICUI)?

Short answer

The MoonshotScore pillars rate business quality, durable growth, positive momentum as strengths. The distress and quality screens read Altman Z 2.67 · Piotroski F 6. Trailing ratios: ROE 2.8% · ROA 2.3% · current ratio 2.37.

4 · What to check next?

What should you watch next at ICU Medical (ICUI)?

Short answer · as of

Current published price targets run low $182.00 · high $200.00 · consensus $192.25 · median $193.50 against a quoted price of $172.52 (as of Nov 20, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.
  • The newest quarter held here (Q3 FY2025) was filed Nov 6, 2025 — 12 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does ICU Medical compare with its peers?

Short answer

ICU Medical's score ranks tied for 6th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
AtriCure, Inc. (ATRC) Same industry, near in market value$55.39 Nov 20, 2026$2.82B95 5-pillar Nov 18, 2026
LeMaitre Vascular, Inc. (LMAT) Same industry, near in market value$74.86 Nov 19, 2026$1.71B88 5-pillar Nov 18, 2026
Haemonetics Corporation (HAE) Same industry, near in market value$120.16 Nov 20, 2026$5.47B83 5-pillar Nov 18, 2026
Merit Medical Systems, Inc. (MMSI) Same industry, near in market value$84.34 Nov 20, 2026$5.05B81 5-pillar Nov 18, 2026
AptarGroup, Inc. (ATR) Same industry, near in market value$140.08 Nov 20, 2026$8.88B77 5-pillar Nov 18, 2026
ICU Medical (ICUI) — this page$172.52$4.31B73
Stevanato Group S.p.A. (STVN) Same industry, near in market value$15.65 Nov 20, 2026$4.27B73 5-pillar Nov 18, 2026
Avantor, Inc. (AVTR) Same industry, near in market value$14.84 Nov 20, 2026$10.1B71 5-pillar Nov 18, 2026
Repligen Corporation (RGEN) Same industry, near in market value$163.81 Nov 20, 2026$10.5B71 5-pillar Nov 18, 2026
Becton, Dickinson and Company (BDX) Named competitor$212.78 Nov 20, 2026$58.0B68 5-pillar Nov 18, 2026
Azenta, Inc. (AZTA) Same industry, near in market value$44.80 Nov 20, 2026$1.87B64 5-pillar Nov 18, 2026
Warby Parker Inc. (WRBY) Same industry, near in market value$23.12 Nov 20, 2026$2.87B62 5-pillar Nov 18, 2026
Teleflex Incorporated (TFX) Same industry, near in market value$161.58 Nov 20, 2026$6.41B61 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$182.00 – $200.00
Consensus target
$192.25
Median target
$193.50

Consensus record · Captured .

Measured against a quoted price of $172.52 (as of Nov 20, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 13, 2026

Transactions
18
Identified insiders
6
Purchases
0
Sales
14
Other transactions
4

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ICUI in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ICUI in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about ICU Medical (ICUI)?

Read these with our analysis →

Investor Questions: ICUI Stock

These answers are editorial: 1 of these 9 answers is drawn from the ICUI research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for ICUI?

ICUI carries the MoonshotScore stated above — the Strong band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. ICU Medical, Inc. specializes in developing, manufacturing, and selling medical devices for infusion therapy and critical care.

Is ICUI a good stock to buy?

Stock Expert AI does not rate ICUI buy, sell or hold. ICU Medical, Inc. carries a MoonshotScore, in the Strong band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the ICUI stock price today?

The last price recorded for ICU Medical, Inc. (ICUI), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the ICUI price target?

The analyst consensus price target for ICU Medical, Inc. (ICUI), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What are the main risks for ICUI?

ICU Medical, Inc. faces several risks that could impact its financial performance and stock price. These include regulatory risks, such as changes in medical device regulations or reimbursement policies; competitive risks, such as competition from larger medical device companies or the emergence of new technologies; and operational risks, such as supply chain disruptions or product liability claims.

What are the key factors to evaluate for ICUI?

ICU Medical, Inc. (ICUI) holds a MoonshotScore in the high range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. By establishing a presence in these markets and tailoring its products to local needs, ICU Medical can tap into a new source of revenue growth. Not financial advice.

How frequently does ICUI data refresh on this page?

ICUI's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven ICUI's recent stock price performance?

ICU Medical, Inc. (ICUI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in infusion therapy and critical care. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ICUI overvalued or undervalued right now?

The trailing P/E of ICU Medical, Inc. (ICUI) is listed under Price & valuation, and the analyst consensus target under Analyst targets & estimates, on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 19 figures on this page — 15 from Financial Modeling Prep (FMP), 3 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.